Emory Diabetes Education Training Academy
Avatar

Management of Hypertension in Patients with Diabetes: What Should the BP Goal Be?

By Emory Diabetes Education Training Academy FEATURING Priyathama Vellanki
By Emory Diabetes Education Training Academy FEATURING Priyathama Vellanki
37 views
May 15, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

62:17
HeartFlow

Chest Pain in Women: CT's role in making an accurate diagnosis

Feat. L. Shaw, M. Gulati

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne
22:14
Practical Ways to Achieve Targets in Diabetes Care

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Feat. S. Nissen
21:10
National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

13:43
Stanford Medicine

What's the Ideal Therapy for Obesity?

Feat. A. Yeoh
34:04
The Texas Heart Institute

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

Feat. G. Bakris
11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

23:28
Inderpreet Madahar

GLP-1/GIP Mechanisms and Clinical Insights

29:04
15th Annual Orange County Symposium for Cardiovascular Disease Prevention

LDL-C: Earlier and Lower Is Better and Safer?

Feat. P. Rosenblit
58:35
University of Colorado Department of Medicine

Updates in Nephrology

Feat. A. Jovanovich
30:00
Piedmont Heart Institute

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Feat. J. Burkle
25:54
13th Orange County Symposium for Cardiovascular Disease Prevention

SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Whic…

Feat. Y. Handelsman